Literature DB >> 15502388

Serial alterations of beta-adrenergic signaling in dilated cardiomyopathic hamsters: possible role of myocardial oxidative stress.

Takao Nishizawa1, Mitsunori Iwase, Hiroaki Kanazawa, Sahoko Ichihara, Gaku Ichihara, Kohzo Nagata, Koji Obata, Kiyoyuki Kitaichi, Toyoharu Yokoi, Masato Watanabe, Takashi Tsunematsu, Yoshihiro Ishikawa, Toyoaki Murohara, Mitsuhiro Yokota.   

Abstract

BACKGROUND: The relationship between enhanced myocardial oxidative stress and impaired beta-adrenergic signaling remains to be characterized during the development of dilated cardiomyopathy. METHODS AND
RESULTS: Alterations in myocardial oxidative stress and beta-adrenergic signaling, as well as left ventricular (LV) functional and structural changes, were evaluated during the development of cardiomyopathy in TO-2 hamsters; F1B hamsters served as controls. LV dysfunction was first apparent at 8 weeks of age and deteriorated thereafter in the TO-2 hamsters. At 32 weeks, the animals exhibited heart failure with an increased plasma norepinephrine concentration. Cardiac myolysis, as demonstrated by elevated plasma concentration of cardiac troponin T, peaked at 8 weeks. The glutathione redox ratio revealed increased oxidative stress in the LV myocardium in TO-2 hamsters even at 4 weeks and became manifest after 8 weeks. The hearts of TO-2 hamsters had significantly reduced superoxide dismutase activity from 8 weeks onward compared with control hamsters. However, glutathione peroxidase activity was unchanged at any time point. The LV functional response to isoproterenol was markedly reduced at 8 weeks, without any apparent changes in the amount of beta-adrenergic signaling molecules, and it deteriorated thereafter. Adenylyl cyclase activity was significantly decreased, despite increased amounts of both G(s) alpha mRNA and protein, in the LV myocardium at 18 weeks.
CONCLUSIONS: Myocardial oxidative stress is actually enhanced in the initial development of LV dysfunction. Both activation of myocardial oxidative stress and impairment of beta-adrenergic signaling become prominent at the stage of severe LV dysfunction. Myocardial oxidative stress may be involved in the development of beta-adrenergic desensitization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15502388     DOI: 10.1253/circj.68.1051

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  11 in total

1.  High-sugar intake does not exacerbate metabolic abnormalities or cardiac dysfunction in genetic cardiomyopathy.

Authors:  Peter A Hecker; Tatiana F Galvao; Karen M O'Shea; Bethany H Brown; Reney Henderson; Heather Riggle; Sachin A Gupte; William C Stanley
Journal:  Nutrition       Date:  2012-02-02       Impact factor: 4.008

2.  Thermogenic responsiveness to beta-adrenergic stimulation is augmented in exercising versus sedentary adults: role of oxidative stress.

Authors:  Christopher Bell; Nicole R Stob; Douglas R Seals
Journal:  J Physiol       Date:  2005-11-24       Impact factor: 5.182

Review 3.  The pathological roles of environmental and redox stresses in cardiovascular diseases.

Authors:  Sahoko Ichihara
Journal:  Environ Health Prev Med       Date:  2012-12-29       Impact factor: 3.674

4.  Hemodynamic alterations in the coronary circulation of cardiomyopathic hamsters: age and Ang II-dependent mechanisms.

Authors:  Nelson Escobales; Jose A Ramos; Guido E Santacana; Maria J Crespo
Journal:  J Card Fail       Date:  2009-08-20       Impact factor: 5.712

5.  Effect of glucose-insulin-potassium infusion on oxidative stress in patients with dilated cardiomyopathy.

Authors:  Emine Diraman; Gunnur Demircan; Sabri Demircan; Mustafa Yazici; Kenan Durna; Firat Ural; Zafer Eren
Journal:  Exp Clin Cardiol       Date:  2008

6.  Myocardial oxidative stress, osteogenic phenotype, and energy metabolism are differentially involved in the initiation and early progression of delta-sarcoglycan-null cardiomyopathy.

Authors:  Comlan Missihoun; David Zisa; Arsalan Shabbir; Huey Lin; Techung Lee
Journal:  Mol Cell Biochem       Date:  2008-08-26       Impact factor: 3.396

7.  Altered gene and protein expression in liver of the obese spontaneously hypertensive/NDmcr-cp rat.

Authors:  Jie Chang; Shinji Oikawa; Gaku Ichihara; Yui Nanpei; Yasuhiro Hotta; Yoshiji Yamada; Saeko Tada-Oikawa; Hitoshi Iwahashi; Emiko Kitagawa; Ichiro Takeuchi; Masao Yuda; Sahoko Ichihara
Journal:  Nutr Metab (Lond)       Date:  2012-09-21       Impact factor: 4.169

8.  δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.

Authors:  Alison M Blain; Volker W Straub
Journal:  Skelet Muscle       Date:  2011-03-17       Impact factor: 4.912

9.  Involvement of oxidative modification of proteins related to ATP synthesis in the left ventricles of hamsters with cardiomyopathy.

Authors:  Sahoko Ichihara; Yuka Suzuki; Jie Chang; Kentaro Kuzuya; Chisa Inoue; Yuki Kitamura; Shinji Oikawa
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

10.  Proteomics analysis identified peroxiredoxin 2 involved in early-phase left ventricular impairment in hamsters with cardiomyopathy.

Authors:  Kentaro Kuzuya; Sahoko Ichihara; Yuka Suzuki; Chisa Inoue; Gaku Ichihara; Syota Kurimoto; Shinji Oikawa
Journal:  PLoS One       Date:  2018-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.